How would you counsel about DMT options for disease-modifying therapy for a patient with multiple sclerosis and positive Hepatitis B surface antigen with negative HBV DNA PCR?

Topics: Neurology • Neuro-immunology

Answer from: at Academic Institution

This is mainly an issue when considering B-cell-depleting medicines, alemtuzumab, and cladribine. For this situation (sAg positive), I would refer to Infectious Disease for their input and co-manage. The patient may need to be on chronic antivirals during immunotherapy, at least for the above medic...

Comments

at University of South Florida College of Medicine
Thank you so much for the reply. I will surely get...

Related Questions